Literature DB >> 6279689

Enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus.

J Shanley, M Myers, B Edmond, R Steele.   

Abstract

Primary varicella-zoster virus (VZV) infection is a serious illness in immunocompromised individuals, and a rapid, sensitive, and reliable assay to identify high-risk VZV-susceptible patients would be clinically useful. An enzyme-linked immunosorbent assay (ELISA) for antibody to VZV was compared with the fluorescent antibody-to-membrane antigen (FAMA) assay and found to be similar in both sensitivity and specificity. The antibody titers determined by both assays were also similar. The absence of antibody detected by ELISA correlated with susceptibility to VZV infection. Because it is simple to perform and has equivalent sensitivity to FAMA, ELISA should be useful for VZV antibody testing in diagnostic and research laboratories.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6279689      PMCID： PMC272061          DOI： 10.1128/jcm.15.2.208-211.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  21 in total

1.  Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation.

Authors:  B Forghani; N J Schmidt; J Dennis
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

2.  Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster.

Authors:  P A Brunell; A A Gershon; S A Uduman; S Steinberg
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

3.  Improved yields of cell-free varicella-zoster virus.

Authors:  N J Schmidt; E H Lennette
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

4.  Quantitation of antibodies to varicella-zoster virus by immune adherence hemagglutination.

Authors:  C L Wong; S Castriciano; M A Chernesky; W E Rawls
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

Review 5.  Passive immunization against varicella-zoster infections and other modes of therapy.

Authors:  P A Brunell; A A Gershon
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

6.  Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence.

Authors:  V Williams; A Gershon; P A Brunell
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

7.  Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.

Authors:  N J Schmidt; E H Lennette; R L Magoffin
Journal:  J Gen Virol       Date:  1969-04       Impact factor: 3.891

8.  Neutralization tests with varicella-zoster virus.

Authors:  A E Caunt; D G Shaw
Journal:  J Hyg (Lond)       Date:  1969-06

9.  Neutralizing antibody responses to varicella-zoster virus.

Authors:  N J Schmidt; E H Lennette
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

10.  Nosocomial varicella. Part I: outbreak in oncology patients at a children's hospital.

Authors:  J D Meyers; M B MacQuarrie; T C Merigan; M H Jennison
Journal:  West J Med       Date:  1979-03
View more
  5 in total

1.  Enzyme-linked immunosorbent assay for detection of streptolysin O antibodies.

Authors:  M Reitano; M A Pisano; L A Eriquez; R F D'Amato
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

2.  Determination of immune status to measles, rubella, and varicella-zoster viruses among medical students: assessment of historical information.

Authors:  D L Murray; M A Lynch
Journal:  Am J Public Health       Date:  1988-07       Impact factor: 9.308

3.  Measurement of antibodies to varicella-zoster virus in a tropical population by enzyme-linked immunosorbent assay.

Authors:  A R Venkitaraman; J M Seigneurin; M Baccard; G M Lenoir; T J John
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

4.  Varicella vaccination in children with lymphoma and solid tumours.

Authors:  S Emir; M Büyükpamukçu; V Köseoğlu; G Hasçelik; C Akyüz; T Kutluk; A Varan
Journal:  Postgrad Med J       Date:  2006-11       Impact factor: 2.401

5.  Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virus.

Authors:  J P Iltis; G A Castellano; P Gerber; C Le; L K Vujcic; G V Quinnan
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.